Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Equity (2022 - 2025)

Historic Return on Equity for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to 0.65%.

  • Atara Biotherapeutics' Return on Equity fell 19800.0% to 0.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.65%, marking a year-over-year decrease of 19800.0%. This contributed to the annual value of 0.87% for FY2024, which is 210400.0% up from last year.
  • As of Q3 2025, Atara Biotherapeutics' Return on Equity stood at 0.65%, which was down 19800.0% from 0.13% recorded in Q2 2025.
  • In the past 5 years, Atara Biotherapeutics' Return on Equity registered a high of 13.39% during Q3 2023, and its lowest value of 8.41% during Q2 2023.
  • Over the past 4 years, Atara Biotherapeutics' median Return on Equity value was 0.56% (recorded in 2025), while the average stood at 0.89%.
  • Examining YoY changes over the last 5 years, Atara Biotherapeutics' Return on Equity showed a top increase of 101500bps in 2024 and a maximum decrease of -120600bps in 2024.
  • Atara Biotherapeutics' Return on Equity (Quarter) stood at 1.46% in 2022, then skyrocketed by 353bps to 3.68% in 2023, then crashed by -75bps to 0.91% in 2024, then crashed by -172bps to 0.65% in 2025.
  • Its last three reported values are 0.65% in Q3 2025, 0.13% for Q2 2025, and 0.21% during Q1 2025.